SCHEMBL1554479

SCHEMBL1554479

FC(F)(F)COc1cccc(Cl)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
L3MBTL1 Q9Y468 3/20 0.39
TSHR P16473 2/20 0.38
CYP3A4 P08684 1/20 0.38
ALDH1A1 P00352 1/20 0.36
RECQL P46063 1/20 0.36
MAPT P10636 2/20 0.36
DRD4 P21917 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
LMNA P02545 2/20 0.35
KCNK3 O14649 1/20 0.35
KCNK9 Q9NPC2 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
POLB P06746 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27852271 0.81 NUDT1 (0.50) HDAC1HDAC6HDAC5L3MBTL1TSHR
SCHEMBL2715350 0.79 L3MBTL1 (0.37) L3MBTL1TSHRALDH1A1RECQLMAPT
SCHEMBL14880366 0.78 MCHR1 (0.42) L3MBTL1TSHRALDH1A1MAPTFFAR4
SCHEMBL22621693 0.78 L3MBTL1 (0.42) L3MBTL1TSHRFFAR4LMNASMN1; SMN2
SCHEMBL14207590 0.78 RXRA (0.44) HDAC1HDAC6L3MBTL1FFAR4LMNA
SCHEMBL29637031 0.78 MCHR1 (0.42) L3MBTL1TSHRALDH1A1MAPTFFAR4
SCHEMBL3386747 0.78 HTR7 (0.51) L3MBTL1TSHRALDH1A1MAPTFFAR4
SCHEMBL27869196 0.77 NUDT1 (0.36) HDAC1HDAC6HDAC5L3MBTL1TSHR
SCHEMBL3966140 0.76 NUDT1 (0.43) L3MBTL1TSHRALDH1A1MAPTLMNA
SCHEMBL18517233 0.75 SCN9A (0.38) L3MBTL1TSHRFFAR4LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107567443-B Biaryl derivatives as GPR120 agonists 株式会社LG化学 2023-04-28 CN disclosed
CN-115925679-A Biaryl derivatives as GPR120 agonists 株式会社LG化学 2023-04-07 CN disclosed
EP-3239143-B1 BIARYL DERIVATIVE AS GPR120 AGONIST LG CHEMICAL LTD (KR) 2023-03-22 EP disclosed
US-20220135574-A1 BIARYL DERIVATIVE AS GPR120 AGONIST LG CHEM, LTD. (KR) 2022-05-05 US disclosed
US-11261186-B2 Biaryl derivative as GPR120 agonist LG CHEM. LTD. (KR) 2022-03-01 US disclosed
CN-107567443-A biaryl derivatives as GPR120 agonists 株式会社LG化学 2018-01-09 CN disclosed
US-20170349594-A1 BIARYL DERIVATIVE AS GPR120 AGONIST LG CHEM, LTD. (KR) 2017-12-07 US disclosed
EP-3239143-A2 BIARYL DERIVATIVE AS GPR120 AGONIST LG Chem, Ltd. (KR) 2017-11-01 EP disclosed
US-9066518-B2 Heterocyclic compounds as pesticides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-06-30 US disclosed
EP-2488030-B1 1-(PYRID-3-YL)-PYRAZOLES AND 1-(PYRIMID-5-YL)-PYRAZOLES AS PEST CONTROLLERS BAYER CROPSCIENCE AG (DE) 2015-01-07 EP disclosed
US-20140221362-A1 Heterocyclic Compounds as Pesticides BAYER CROPSCIENCE AG (DE) 2014-08-07 US disclosed
EP-2488030-A1 1- (PYRID-3-YL) -PYRAZOLE AND 1- (PYRIMID-5-YL) -PYRAZOLE AS PESTICIDE Bayer CropScience AG (DE) 2012-08-22 EP disclosed
US-20110166143-A1 Heterocyclic Compounds as Pesticides BAYER CROPSCIENCE AG (DE) 2011-07-07 US disclosed
WO-2011045224-A1 1- (PYRID-3-YL) -PYRAZOLE AND 1- (PYRIMID-5-YL) -PYRAZOLE AS PESTICIDE BAYER CROPSCIENCE AG (DE) 2011-04-21 WO disclosed
US-4409228-A ANOREXIGENIC AGENTS SANOFI (FR) 1983-10-11 US disclosed
EP-0021973-B1 ANORECTIC AMINO PIPERIDINES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM SANOFI S.A. (FR) 1982-12-08 EP disclosed
EP-0045980-A1 Compounds useful in the preparation of aminopiperidines with anorectic properties SANOFI S.A. (FR) 1982-02-17 EP disclosed
EP-0021973-A2 Anorectic amino piperidines, process for their preparation and medicaments containing them SANOFI S.A. (FR) 1981-01-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220135574-A1 BIARYL DERIVATIVE AS GPR120 AGONIST GPR119, GLP1R, GIPR HDAC1 1633/4885HDAC6 2712/4885HDAC5 1289/4885
US-20140221362-A1 Heterocyclic Compounds as Pesticides DDT, ACHE, BCHE HDAC1 543/4885HDAC6 1081/4885HDAC5 836/4885
US-20170349594-A1 BIARYL DERIVATIVE AS GPR120 AGONIST GPR119, GLP1R, GIPR HDAC1 1633/4885HDAC6 2712/4885HDAC5 1289/4885
US-11261186-B2 Biaryl derivative as GPR120 agonist GPR119, GPR88, FFAR1 HDAC1 1767/4885HDAC6 2798/4885HDAC5 1462/4885
US-20110166143-A1 Heterocyclic Compounds as Pesticides DDT, ACHE, BCHE HDAC1 543/4885HDAC6 1081/4885HDAC5 836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.